Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXN5CE
|
||||
| Drug Name |
N3-(3-(1-methylpiperidin-4-yl)phenyl)-1-(pyridin-2-yl)-1H-1,2,4-triazole-3,5-diamine
|
||||
| Synonyms |
CHEMBL1835868
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C19H23N7
|
||||
| Canonical SMILES |
CN1CCC(CC1)c2cccc(Nc3nc(N)n(n3)c4ccccn4)c2
|
||||
| InChI |
InChI=1S/C19H23N7/c1-25-11-8-14(9-12-25)15-5-4-6-16(13-15)22-19-23-18(20)26(24-19)17-7-2-3-10-21-17/h2-7,10,13-14H,8-9,11-12H2,1H3,(H3,20,22,23,24)
|
||||
| InChIKey |
OUEQZEHZIJMBLB-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | FL cytokine receptor | Target Info | [1587926] | ||
| Mast/stem cell growth factor receptor | Target Info | [1587926] | |||
| KEGG Pathway | Cytokine-cytokine receptor interaction | ||||
| Hematopoietic cell lineage | |||||
| Pathways in cancer | |||||
| Transcriptional misregulation in cancer | |||||
| Acute myeloid leukemia | |||||
| Central carbon metabolism in cancerhsa04014:Ras signaling pathway | |||||
| Rap1 signaling pathway | |||||
| Endocytosis | |||||
| PI3K-Akt signaling pathway | |||||
| Melanogenesis | |||||
| Central carbon metabolism in cancer | |||||
| Pathway Interaction Database | C-MYB transcription factor network | ||||
| Signaling events mediated by Stem cell factor receptor (c-Kit) | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.